NCT04211298 is a Phase 4 clinical trial of Dexmedetomidine in Sedation Complication, sponsored by Rabin Medical Center.

Who is sponsoring NCT04211298?

NCT04211298 is sponsored by Rabin Medical Center.

What drugs are being tested in NCT04211298?

Interventions in NCT04211298: Dexmedetomidine, Propofol.

What condition does NCT04211298 study?

NCT04211298 studies Sedation Complication.

Is NCT04211298 still recruiting?

NCT04211298 is currently status unknown. Last updated 26 December 2019.

Last reviewed 2019-12-26 · How we verify

NCT04211298

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexmedetomidine Versus Propofol Sedation in Flexible Bronchoscopy: A Randomized Controlled Trial

Status unknown Phase 4 Last updated 26 December 2019

What this trial tests

Phase 4 trial testing Dexmedetomidine in Sedation Complication in 100 participants. Status unknown.

Timeline

1 December 2019

Primary endpoint
30 May 2020

1 August 2020

Quick facts

Lead sponsor	Rabin Medical Center
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 December 2019
Primary completion	30 May 2020
Estimated completion	1 August 2020
Sites	1 location across Israel

Drugs / interventions tested

Dexmedetomidine (dexmedetomidine) — full drug profile →
Propofol (Propofol) — full drug profile →

Conditions studied

Sedation Complication — all drugs for Sedation Complication →

Sponsor

Rabin Medical Center

Who can join

Eligibility, any sex, with Sedation Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will evaluate clinical outcomes during bronchoscopy procedures with dexmedetomidine in comparison to propofol. The clinical outcomes that will be evaluated are: oxygen saturation, transcutaneous Pco2, blood pressure and complications

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Dexmedetomidine versus propofol sedation in flexible bronchoscopy: a randomized controlled trial.
Pertzov B, Krasulya B, Azem K, Shostak Y, et al · · 2022 · cited 13× · PMID 35291989 · DOI 10.1186/s12890-022-01880-9
Dexmedetomidine Versus Propofol Sedation in Flexible Bronchoscopy: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis
Pertzov B, Krasulya B, Azem K, Shostak Y, et al · · 2022 · DOI 10.21203/rs.3.rs-1218948/v1

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting

Other recruiting trials for Sedation Complication

Currently open trials in the same condition.

NCT06667869 — multipaRameter mOnitoring systeM for sedAtion iNThe ICu · recruiting
NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
NCT06769308 — Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients · NA · recruiting
NCT05371886 — Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal · NA · recruiting
NCT05765162 — Safe Brain Initiative, Operationalizing Precision Anaesthesia · recruiting

Other Rabin Medical Center trials

Trials by the same sponsor.

NCT06837909 — Transversus Abdominis Plane Block Versus Wound Infiltration for Pulmonary Function Preservation Following Laparoscopic L · NA · recruiting
NCT06951399 — Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07208240 — Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST T · Phase 1, PHASE2 · recruiting
NCT06931119 — Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients · Phase 1 · not yet recruiting
NCT06966427 — Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Inje · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04211298 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rabin Medical Center
Last refreshed: 26 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04211298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing